| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $225,510,033 ) (Continued on the next page) |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG071870 | Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females | 001 | 5 | NIH | 6/17/2025 | $55,401 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG071870 | Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females | 000 | 5 | NIH | 3/6/2025 | $623,274 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136035 | Interleukin-10 mediated immune cell-adipocyte crosstalk in adipose thermogenesis | 001 | 2 | NIH | 6/12/2025 | $61,861 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136035 | Interleukin-10 mediated immune cell-adipocyte crosstalk in adipose thermogenesis | 000 | 2 | NIH | 2/20/2025 | $556,760 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA251754 | Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health | 001 | 5 | NIH | 5/23/2025 | $69,595 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA251754 | Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health | 000 | 5 | NIH | 3/17/2025 | $626,369 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA049547 | Atherosclerosis in cocaine addiction: imaging risk with PET/MR | 001 | 4 | NIH | 4/11/2025 | $75,205 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA049547 | Atherosclerosis in cocaine addiction: imaging risk with PET/MR | 000 | 4 | NIH | 3/17/2025 | $676,860 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AI162223 | Single cell transcriptomics of HIV persistence and latency | 000 | 5 | NIH | 3/20/2025 | $628,679 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK107670 | The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia | 001 | 9 | NIH | 5/9/2025 | $57,064 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK107670 | The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia | 000 | 9 | NIH | 3/14/2025 | $513,586 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173318 | Mechanisms of de novo cardiac sarcomere assembly | 000 | 2 | NIH | 3/14/2025 | $600,471 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA248981 | Developing and Testing a Digital Toolkit to Improve Colorectal Cancer Screening Rates in Federally Qualified Health Centers | 001 | 5 | NIH | 5/22/2025 | $66,533 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA248981 | Developing and Testing a Digital Toolkit to Improve Colorectal Cancer Screening Rates in Federally Qualified Health Centers | 000 | 5 | NIH | 3/19/2025 | $598,792 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA271604 | Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors | 000 | 3 | NIH | 3/4/2025 | $628,104 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA271604 | Modeling Best Approaches for Cardiovascular Disease Prevention in Cancer Survivors | 001 | 3 | NIH | 5/22/2025 | $69,790 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH124839 | 3/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact | 000 | 5 | NIH | 2/14/2025 | $301,273 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K08HL173639 | Precision Prediction of Right Ventricular Size, Function, and Outcomes in Patients with Repaired Tetralogy of Fallot | 000 | 1 | NIH | 2/24/2025 | $167,588 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS127442 | The Role of Core Circadian Regulator Bmal1 in Axonal Regeneration and Nerve Repair | 000 | 3 | NIH | 2/14/2025 | $502,613 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HG013350 | Systematic integration of variant interpretation tools into genetic and genomic risk prediction | 001 | 2 | NIH | 4/24/2025 | $60,141 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HG013350 | Systematic integration of variant interpretation tools into genetic and genomic risk prediction | 000 | 2 | NIH | 2/14/2025 | $541,262 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01AG087324 | Leveraging large-scale genomics to dissect A-to-I editing in brain aging and Alzheimer's disease | 000 | 2 | NIH | 2/14/2025 | $508,112 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K08HL163489 | The Role of PPM1D in Myeloproliferative Neoplasms | 000 | 3 | NIH | 3/10/2025 | $164,404 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31CA280993 | Merkel cell polyomavirus T-Antigen mediated reprogramming in adult epidermis | 000 | 2 | NIH | 3/3/2025 | $47,374 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R50CA276021 | NCI Research Specialist (Clinician Scientist) Award | 000 | 3 | NIH | 3/18/2025 | $91,123 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F31CA280993 | Merkel cell polyomavirus T-Antigen mediated reprogramming in adult epidermis | 001 | 2 | NIH | 5/22/2025 | $564 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA051191 | Molecular Neurobiology of Human Opioid Use Disorder | 001 | 5 | NIH | 4/11/2025 | $58,639 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA051191 | Molecular Neurobiology of Human Opioid Use Disorder | 000 | 5 | NIH | 3/17/2025 | $527,758 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173456 | Microfluidic organoid model of cardio-hepatic physiology and disease | 000 | 2 | NIH | 3/11/2025 | $495,329 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA260711 | Impact of mutational order on molecular mechanisms of oncogenesis | 001 | 4 | NIH | 5/23/2025 | $64,801 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA260711 | Impact of mutational order on molecular mechanisms of oncogenesis | 000 | 4 | NIH | 2/17/2025 | $583,211 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH118297 | Maturation of frontal cortico-thalamic circuitry in control of social behavior | 002 | 7 | NIH | 3/27/2025 | $565,819 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA269954 | HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer | 001 | 3 | NIH | 5/22/2025 | $66,717 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA269954 | HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer | 000 | 3 | NIH | 2/14/2025 | $600,457 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK138369 | The KQ1 serum study: soluble biomarkers for T1D risk, development & progression | 000 | 2 | NIH | 2/14/2025 | $1,095,529 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH129372 | Functional mapping of noncoding regulatory variants in human neuronal subtypes3. | 000 | 4 | NIH | 2/14/2025 | $543,751 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32AG082483 | Investigating the role of an EIF2B3 variant as an Alzheimer's disease risk modifier | 001 | 3 | NIH | 6/23/2025 | $1,284 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | F32AG082483 | Investigating the role of an EIF2B3 variant as an Alzheimer's disease risk modifier | 000 | 3 | NIH | 3/12/2025 | $79,756 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA290438 | Artificial intelligence enabled Stroma-Weighted Automated Grading system to improve risk stratification in Black Men | 000 | 1 | NIH | 3/12/2025 | $717,667 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK112978 | The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | 000 | 7 | NIH | 3/5/2025 | $577,304 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EY037134 | Nicotinic modulation of deep layer somatostatin interneurons for visual critical period plasticity | 000 | 1 | NIH | 3/13/2025 | $562,660 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK112978 | The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | 002 | 7 | NIH | 6/11/2025 | $64,146 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 001 | 2 | NIH | 5/21/2025 | $33,799 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 000 | 2 | NIH | 3/4/2025 | $304,201 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL171695 | Comprehensive Patient-centered Home-based care coaching for COPD self-management | 000 | 2 | NIH | 2/26/2025 | $610,261 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD102614 | FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE) | 001 | 5 | NIH | 5/1/2025 | $36,335 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD102614 | FUNCTIONAL CHARACTERIZATION OF NOVEL DETERMINANTS OF HOLOPROSENCEPHALY (HPE) | 000 | 5 | NIH | 2/19/2025 | $327,015 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01DA053629 | Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | 001 | 5 | NIH | 4/8/2025 | $164,155 |
| | 2025 | 2025 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01DA053629 | Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice | 000 | 5 | NIH | 2/26/2025 | $1,477,403 |
|
